These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 11857395)
21. The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas. Tan P; Cady B; Wanner M; Worland P; Cukor B; Magi-Galluzzi C; Lavin P; Draetta G; Pagano M; Loda M Cancer Res; 1997 Apr; 57(7):1259-63. PubMed ID: 9102210 [TBL] [Abstract][Full Text] [Related]
22. PS2 protein in breast carcinomas: cut-off value of estrogen-regulated expression. Nikolić-Vukosavljević D; Grujić-Adanja G; Janković R; Nesković-Konstantinović Z; Branković-Magić M Neoplasma; 2001; 48(1):1-6. PubMed ID: 11327531 [TBL] [Abstract][Full Text] [Related]
23. Association between HER-2/neu and the progesterone receptor in oestrogen-dependent breast cancer is age-related. Huang HJ; Neven P; Drijkoningen M; Paridaens R; Wildiers H; Van Limbergen E; Berteloot P; Amant F; Christiaens MR; Vergote I Breast Cancer Res Treat; 2005 May; 91(1):81-7. PubMed ID: 15868434 [TBL] [Abstract][Full Text] [Related]
24. Comparison of HER-2/neu, ER and PCNA expression in premenopausal and postmenopausal patients with breast carcinoma. Zheng W; Zheng J; Ma L; Meng F; Huang L; Ma D APMIS; 2005 Mar; 113(3):175-81. PubMed ID: 15799760 [TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of EGFR, p185(erbB-2), Bcl-2 and p53 in breast carcinomas in pre-menopausal and post-menopausal women. Talley L; Chhieng DC; Bell WC; Grizzle WE; Frost AR Biotech Histochem; 2008 Feb; 83(1):5-14. PubMed ID: 18568671 [TBL] [Abstract][Full Text] [Related]
26. The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. Turkoz FP; Solak M; Petekkaya I; Keskin O; Kertmen N; Sarici F; Arik Z; Babacan T; Ozisik Y; Altundag K J BUON; 2013; 18(2):335-41. PubMed ID: 23818343 [TBL] [Abstract][Full Text] [Related]
27. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer. Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548 [TBL] [Abstract][Full Text] [Related]
28. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment. Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452 [TBL] [Abstract][Full Text] [Related]
29. Breast infiltrating ductal carcinoma: analysis of hormone, HER-2 receptors and Ki-67 proliferation marker. Mustać E; Zamolo G; Petković M; Dordević G; Radić J; Grgurević E; Batinac T Coll Antropol; 2008 Sep; 32(3):741-6. PubMed ID: 18982746 [TBL] [Abstract][Full Text] [Related]
30. Effects of estradiol and medroxyprogesterone acetate on expression of the cell cycle proteins cyclin D1, p21 and p27 in cultured human breast tissues. Eigeliene N; Härkönen P; Erkkola R Cell Cycle; 2008 Jan; 7(1):71-80. PubMed ID: 18196959 [TBL] [Abstract][Full Text] [Related]
31. Cell cycle proteins do not predict outcome in grade I infiltrating ductal carcinoma of the breast. Leong AC; Hanby AM; Potts HW; Tan DS; Skilton D; Ryder K; Harris WH; Liebmann RD; Barnes DM; Gillett CE Int J Cancer; 2000 Jan; 89(1):26-31. PubMed ID: 10719727 [TBL] [Abstract][Full Text] [Related]
32. Adult weight gain in relation to breast cancer risk by estrogen and progesterone receptor status: a meta-analysis. Vrieling A; Buck K; Kaaks R; Chang-Claude J Breast Cancer Res Treat; 2010 Oct; 123(3):641-9. PubMed ID: 20711809 [TBL] [Abstract][Full Text] [Related]
33. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
34. Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index. Santa-Maria CA; Yan J; Xie XJ; Euhus DM Int J Clin Oncol; 2015 Apr; 20(2):317-23. PubMed ID: 24913910 [TBL] [Abstract][Full Text] [Related]
35. Breast cancer in young women and prognosis: How important are proliferation markers? Fredholm H; Magnusson K; Lindström LS; Tobin NP; Lindman H; Bergh J; Holmberg L; Pontén F; Frisell J; Fredriksson I Eur J Cancer; 2017 Oct; 84():278-289. PubMed ID: 28844016 [TBL] [Abstract][Full Text] [Related]
36. The effect of estrogen usage on the subsequent hormone receptor status of primary breast cancer. Lower EE; Blau R; Gazder P; Stahl DL Breast Cancer Res Treat; 1999 Dec; 58(3):205-11. PubMed ID: 10718482 [TBL] [Abstract][Full Text] [Related]
37. Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women. de Sousa Almeida-Filho B; De Luca Vespoli H; Pessoa EC; Machado M; Nahas-Neto J; Nahas EAP J Steroid Biochem Mol Biol; 2017 Nov; 174():284-289. PubMed ID: 29031688 [TBL] [Abstract][Full Text] [Related]
38. Breast cancer in Tunisia: association of body mass index with histopathological aspects of tumors. Bouguerra H; Guissouma H; Labidi S; Stambouli N; Marrakchi R; Chouaib S; Ben Ammar Elgaaied A; Boussen H; Gati A Asian Pac J Cancer Prev; 2014; 15(16):6805-10. PubMed ID: 25169529 [TBL] [Abstract][Full Text] [Related]
39. ER, PgR, Ki67, p27(Kip1), and histological grade as predictors of pathological complete response in patients with HER2-positive breast cancer receiving neoadjuvant chemotherapy using taxanes followed by fluorouracil, epirubicin, and cyclophosphamide concomitant with trastuzumab. Kurozumi S; Inoue K; Takei H; Matsumoto H; Kurosumi M; Horiguchi J; Takeyoshi I; Oyama T BMC Cancer; 2015 Sep; 15():622. PubMed ID: 26345461 [TBL] [Abstract][Full Text] [Related]
40. Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy. Filipits M; Rudas M; Heinzl H; Jakesz R; Kubista E; Lax S; Schippinger W; Dietze O; Greil R; Stiglbauer W; Kwasny W; Nader A; Stierer M; Gnant MF; Clin Cancer Res; 2009 Sep; 15(18):5888-94. PubMed ID: 19723645 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]